kabutan

CHUGAI PHARMACEUTICAL CO., LTD., July-September (3Q) Net Income Increases by 41%, Current Fiscal Year Dividend Revised from 82 yen to Undecided

Fri Oct 25, 2024 5:00 pm JST Earnings

4519 CHUGAI PHARMACEUTICAL CO., LTD. 【IFRS】

Earnings Report

CHUGAI PHARMACEUTICAL CO., LTD. <4519> [TSE-P] announced its financial results (based on IFRS) after the market closed on October 25th (17:00). The consolidated net income for the cumulative third quarter of the fiscal year ending December 2024 (January to September) increased by 26.2% from the same period last year, reaching 295 billion yen.

At the same time, the plan for a annual dividend of 82 yen has been changed to undecided.

In the most recent three-month period, from July to September (3Q), the consolidated net income increased by 41.2% from the same period last year, reaching 109 billion yen. The operating profit margin rose from 41.4% in the same period last year to 50.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 821,231 383,835 381,950 271,950 165.4 71.9 Oct 24, 2022 IFRS
Jan - Sep, 2023 837,555 317,598 321,131 234,266 142.4 72.4 Oct 24, 2023 IFRS
Jan - Sep, 2024 868,538 418,602 417,527 295,758 179.8 ー Oct 25, 2024 IFRS
YoY +3.7% +31.8% +30.0% +26.2% +26.2%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 Prev 517,140 ー ー ー － 41 Jul 25, 2024 IFRS
Jul - Dec, 2024 New 597,140 ー ー ー － － Oct 25, 2024 IFRS
Revision Rate +15.5% － － － －

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Prev 1,070,000 ー ー ー － 82 Feb 1, 2024 IFRS
Dec, 2024 New 1,150,000 ー ー ー － － Oct 25, 2024 IFRS
Revision Rate +7.5% － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2023 531,710 228,264 230,165 168,779 102.6 40 Feb 1, 2024 IFRS
Jul - Dec, 2024 Guidance 597,140 ー ー ー － － Oct 25, 2024 IFRS
YoY +12.3% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 1,259,726 533,309 531,166 374,429 227.6 78 Feb 2, 2023 IFRS
Dec, 2023 1,111,367 439,174 443,821 325,472 197.8 80 Feb 1, 2024 IFRS
Dec, 2024 Guidance 1,150,000 ー ー ー － － Oct 25, 2024 IFRS
YoY +3.5% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 257,898 106,688 107,475 77,573 47.2 41.4 Oct 24, 2023 IFRS
Oct - Dec, 2023 273,812 121,576 122,690 91,206 55.4 44.4 Feb 1, 2024 IFRS
Jan - Mar, 2024 236,949 99,874 99,889 74,401 45.2 42.1 Apr 24, 2024 IFRS
Apr - Jun, 2024 315,911 158,321 158,801 111,861 68.0 50.1 Jul 25, 2024 IFRS
Jul - Sep, 2024 315,678 160,407 158,837 109,496 66.6 50.8 Oct 25, 2024 IFRS
YoY +22.4% +50.4% +47.8% +41.2% +41.1%

Related Articles